Publications

Better decisions begin with deeper understanding.

Explore the expertise, insights, and perspectives from OPEN Health that help transform complexity into clarity across today’s healthcare landscape.

Showing 571–580 of 763 publications

Stacked bar chart comparing satisfaction levels for three groups: Placebo+IDC, RBP-6000 300/100mg+IDC, and RBP-6000 300/300mg+IDC, showing increased satisfaction in the RBP-6000 groups.

Publications

Patient-centered outcomes in participants of a buprenorphine monthly depot (BUP-XR) double-blind, placebo-controlled, multicenter, phase 3 study

A flowchart showing three feedback rounds with groups in London, Basel, Chicago, WGs, and public, leading to five stages of PEGQ versions, from PEGQ 1.0 to PEGQ 1.5.

Publications

Co-creation of patient engagement quality guidance for medicines development: an international multistakeholder initiative

Table showing mean utility values (SD) for health states of 210 patients: Newly diagnosed 0.63, Induction 0.16, Consolidation 0.57, Maintenance 0.89, ≥1 yr follow-up 0.89, failure 0.51, SCT -0.25, recovery 0.71, SCT >1 yr no complications 0.89, SCT >1 yr GVHD 0.37.

Publications

Value of hospital Antimicrobial Stewardship Programs [ASPs]: a systematic review

Table showing mean utility values (SD) for health states of 210 patients: Newly diagnosed 0.63, Induction 0.16, Consolidation 0.57, Maintenance 0.89, ≥1 yr follow-up 0.89, failure 0.51, SCT -0.25, recovery 0.71, SCT >1 yr no complications 0.89, SCT >1 yr GVHD 0.37.

Publications

Health state utilities for acute myeloid leukaemia: a time trade-off study

A person wearing a white medical coat and stethoscope writes on a clipboard, with sunlight streaming in from a window.

Publications

Cost-effectiveness analysis of standalone trabecular micro-bypass stents in patients with mild-to-moderate open-angle glaucoma in Canada

A pile of yellowish capsules scattered on a white surface.

Publications

Impact of medical marijuana legalization on opioid use, chronic opioid use, and high-risk opioid use

Scatter plot showing the cost-effectiveness plane with incremental cost versus incremental QALY; light triangles for PSA results, a diamond for deterministic result, and a square denoting the mean PSA result.

Publications

Cost-effectiveness of teriflunomide compared to interferon beta-1b for relapsing multiple sclerosis patients in China

A cross-section illustration of a blood vessel showing red blood cells flowing through it, with other blood vessels visible in the background.

Publications

Pulmonary Embolism in Europe – burden of illness in relationship to healthcare resource utilization and return to work

Line graph showing cost-effectiveness acceptability curves for ALEM vs OCR under various model scenarios, with willingness-to-pay threshold (x-axis) and model cost-effectiveness (y-axis), and a legend explaining each scenario.

Publications

Cost-effectiveness of alemtuzumab in the treatment of relapsing forms of multiple sclerosis in the United States

Flowchart of patient selection criteria for HAE study and HCRU population, showing groups based on medication prescriptions, continuous enrolment, and CVAD use, with sample sizes at each step.

Publications

Treatment patterns and healthcare resource utilization among patients with hereditary angioedema in the United States